We have studied the inheritance of several polymorphic Xq27/28 DNA marker loci in two three generation families with the X linked neonatal lethal form of centronuclear/myotubular myopathy (XL MTM). We found complete linkage of XLMTM to all four informative Xq28 markers analysed, with GCPIRCP (Z=3-876, 0=0.00), with DXS15 (Z= 3.737, 0=0-00), with DXS52 (Z=2*709, 0=0-00), and with F8C (Z= 1-020, 0=0.00). In mitochondria, glycogen, and large nuclei, singly or in chains. This central area is similar in appearance to the myotubes seen in fetal muscle. Central nuclei are seen in other neonatal myopathies, including congenital myotonic dystrophy, but do not usually persist in these conditions, either in tissue culture or in muscle biopsies taken at a later stage. In contrast, the myotubular appearance does persist in the severe neonatal MTM, being found after tissue culture for several weeks,5 and on repeat muscle biopsy after many months.6 This supports the concept of this form of MTM displaying a maturational arrest of muscle ultrastructural development, and so the pathogenetic term 'myotubular' is preferred by some to the purely descriptive 'centronuclear', although neither word encompasses all the pathological characteristics of the disorder. 4 There are some features of MTM that suggest a neurogenic element in its aetiology. Thus, degeneration and regeneration have been described in axons of the sciatic nerve of a male infant who died at 9 months.6 The fact that this boy survived for so long might indicate, however, that the diagnosis in his case could be distinct from the X linked severe neonatal form considered in this paper. In another study, electromyography indicated 
Myotubular myopathy (MTM) was first described in
1966 by Spiro et all in an isolated male infant. Subsequently, a severe neonatal form of this condition has been well documented that is usually X linked.24 There is severe generalised hypotonia and muscle weakness, with consequent respiratory embarrassment; affected males often die in utero, in the neonatal period, or within the first three years of life. Muscle biopsy shows hypotrophic fibres characterised by a central area devoid of myofibrils but containing mitochondria, glycogen, and large nuclei, singly or in chains. This central area is similar in appearance to the myotubes seen in fetal muscle. Central nuclei are seen in other neonatal myopathies, including congenital myotonic dystrophy, but do not usually persist in these conditions, either in tissue culture or in muscle biopsies taken at a later stage. In contrast, the myotubular appearance does persist in the severe neonatal MTM, being found after tissue culture for several weeks,5 and on repeat muscle biopsy after many months.6 This supports the concept of this form of MTM displaying a maturational arrest of muscle ultrastructural development, and so the pathogenetic term 'myotubular' is preferred by some to the purely descriptive 'centronuclear', although neither word encompasses all the pathological characteristics of the disorder. 4 There are some features of MTM that suggest a neurogenic element in its aetiology. Thus, degeneration and regeneration have been described in axons of the sciatic nerve of a male infant who died at 9 months. 6 
Pedigrees and DNA probe results. DNA was digested with appropriate restriction enzymes and buffers using conditions recommended by the suppliers. The digested DNA was separated by electrophoresis in 0-8% agarose gels, and then transferred to nylon membranes by Southern blotting in 0-7 mol/l ammonium acetate, 0-01 mol/l sodium hydroxide. The membranes were dried and the DNA was bound to the membrane by exposure to UV light (268 nm) for 40 seconds. The membranes were prehybridised in 1 mol/l sodium chloride, 0 05 mol/l Tris (pH 7-5), 1% sodium dodecyl sulphate (SDS), and 10% dextran sulphate at 65°C for at least two hours. The DNA probes, in the form of inserts excised from their parent plasmids, were radiolabelled by the random oligonucleotide method9 to a specific activity of 5 x107 to 1 x 108 dpm/tg. The denatured probe was added to the hybridisation mix and incubation continued at 65°C for 18 to 20 hours. Posthybridisation washes were initially in 2 x SSC, 0-1% SDS for 2x5 minutes at 65°C (SSC is 0-15 mol/l sodium chloride, 0-015 mol/l sodium citrate). The stringency was increased by sequential washing of the membranes in a decreasing concentration of SSC (1 x to O lx) and 0-1% SDS at 65°C, depending on the strength of the radioactive signal. The washed membranes were exposed to Fuji x ray film, with Cronex intensifying screens for one to seven days at -700C.
The panel of DNA probes used covered the major areas of the X chromosome. The DNA probe results were analysed for linkage to the disease locus using the computer package LINKAGE (version 4.7). ' 
Results

HISTOPATHOLOGY
The results of the detailed examination of the muscle biopsies from affected males, and from obligate and possible carrier females, will be reported separately in a paper by Braga et al. It is important here, however, to report the results in family 1: muscle biopsies from the obligate carrier grandmother (I 1) and all of her daughters showed myopathic changes strongly suggestive of X linked MTM. All these women, therefore, have been classified as carriers for the purposes of the DNA study. In this family, three of the six phase unknown meioses, and two of the four phase known meioses, depend upon this classification being correct.
DNA STUDY
Preliminary linkage analysis on family 1 in 1984 used a limited panel of DNA probes from Xp22 to Xq21. Of these, only D2 (DXS43), L128 (DXS7), DP34 (DX YS1), and p212 (DXS178) were at all informative. Probes RC8 (DXS9) and p754 (DXS84) were uninformative. No evidence of linkage to any of these loci was found.
Recent studies have used usefully polymorphic probes from the distal long arm of the X chromosome.
We have linkage data using markers 1 14-12 (F8C)," Stl4 (DXS52), DX13 (DXS15), and hs7, the red/green pigment gene CBD/CBP. 12 
